Inside the fall of 23andMe
Read more at CNBC
-
23andMe’s stock falls after company says there’s substantial doubt it can stay in business
Business - MarketWatch - November 12 -
FedExCup Fall update: Nico Echavarria nears Next 10; Joel Dahmen inside top 125 after sponsor invite
Sports - Yahoo Sports - October 27 -
DNA-testing site 23andMe fights for survival
Top stories - BBC News - November 3 -
23andMe appoints three new board members following abrupt resignations
Business - CNBC - October 29 -
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
Business - MarketWatch - November 12 -
DNA-testing site 23andMe to lay off 40% of its workers
Top stories - BBC News - November 12 -
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
Business - The Wall Street Journal - November 11 -
23andMe warns of ‘substantial doubt’ over its survival without new funding
Business - Financial Times - November 12 -
23andMe cuts 40% of its workforce and discontinues therapeutics division
Health - ABC News - November 12
More from CNBC
-
Bitcoin hits fresh record, races toward $100,000 as rally continues
Business - CNBC - 36 minutes ago -
Target's recent trade imports data tells the real story behind massive earnings miss
Business - CNBC - 1 hour ago -
Nvidia shares fluctuate as investors digest third-quarter earnings
Business - CNBC - 6 minutes ago -
Snowflake shares rocket 30% and head for best day ever after earnings beat
Business - CNBC - 25 minutes ago -
CFPB expands oversight of digital payments services including Apple Pay, Cash App, PayPal and Zelle
Business - CNBC - 1 hour ago